PubMed:33338232 / 0-155
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3 | 0-10 | Chemical | denotes | Sofosbuvir | MESH:D000069474 |
| 4 | 15-26 | Chemical | denotes | daclatasvir | MESH:C549273 |
| 5 | 48-56 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-114 | Sentence | denotes | Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial. |
| T2 | 115-128 | Sentence | denotes | INTRODUCTION: |